Literature DB >> 9160922

Palliative care in patients with cancer of the head and neck.

K Forbes1.   

Abstract

Palliative care is the active total care of patients whose disease is not responsive to curative treatment. Patients with end-stage head and neck cancer have particular problems because of the impact of the tumour on the airway, the upper gastrointestinal tract and the major senses. Patients referred for palliative care were identified from the hospice database and the nature, incidence and management of their problems, and the role of the hospice in their care, was reviewed from in-patient and home care notes and patient-generated problem lists. Thirty-two male and six female patients with a median age of 64 years were identified. Locoregional recurrence was present in 79% of patients. Pain, weight loss, feeding difficulties, dysphagia, respiratory symptoms, xerostomia, oral thrush and communication difficulties were the major problems. The management of each, and of the terminal events encountered in the group, is discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9160922     DOI: 10.1046/j.1365-2273.1997.00872.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  7 in total

1.  Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer.

Authors:  Carolyn L Mulvey; Thomas J Smith; Christine G Gourin
Journal:  Head Neck       Date:  2015-06-16       Impact factor: 3.147

2.  Towards a pain free hospital: an in-depth qualitative analysis of the pain experiences of head and neck cancer patients undergoing radiotherapy.

Authors:  Natalie Pattison; Matthew Rd Brown; Anthony Gubbay; Janet Peacock; Joy R Ross; Suzanne Chapman; Odile Sauzet; John Williams
Journal:  Br J Pain       Date:  2015-09-23

3.  [Chronic pain therapy for patients with head and neck tumors].

Authors:  A Walz; B Haberland; B Wollenberg; C Bausewein
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

4.  Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.

Authors:  Markus S Anker; Richard Holcomb; Maurizio Muscaritoli; Stephan von Haehling; Wilhelm Haverkamp; Aminah Jatoi; John E Morley; Florian Strasser; Ulf Landmesser; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02       Impact factor: 12.910

5.  Physicians' clinical prediction of survival in head and neck cancer patients in the palliative phase.

Authors:  Arta Hoesseini; Marinella P J Offerman; Bojou J van de Wall-Neecke; Aniel Sewnaik; Marjan H Wieringa; Robert J Baatenburg de Jong
Journal:  BMC Palliat Care       Date:  2020-11-24       Impact factor: 3.234

6.  Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.

Authors:  David M Cognetti; Jennifer M Johnson; Joseph M Curry; Samith T Kochuparambil; Darren McDonald; Frank Mott; Mary J Fidler; Kerstin Stenson; Nilesh R Vasan; Mohammad A Razaq; John Campana; Patrick Ha; Grace Mann; Kosuke Ishida; Miguel Garcia-Guzman; Merrill Biel; Ann M Gillenwater
Journal:  Head Neck       Date:  2021-10-09       Impact factor: 3.821

Review 7.  The palliative care needs and experiences of people with advanced head and neck cancer: A scoping review.

Authors:  Catriona R Mayland; Qiaoling Marilyn Ho; Hannah C Doughty; Simon N Rogers; Prithvi Peddinti; Praytush Chada; Stephen Mason; Matthew Cooper; Paola Dey
Journal:  Palliat Med       Date:  2020-10-21       Impact factor: 4.762

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.